Global Health

Global Health Debt/EBITDA

The Total Debt to EBITDA Ratio of Global Health (MEDANTA.NS) as of Nov 12, 2026 is 1.71. In the previous year, Total Debt to EBITDA Ratio was 0.77 — a change of 121.49% (higher).

Debt/EBITDA

1.71

YoY

121.49%

Last updated:

Total Debt to EBITDA Ratio of Global Health is 2026 1.71 . Total Debt to EBITDA Ratio of Global Health was 2025 0.77 . It decreases by 121.49% higher compared to the previous year.

The Global Health Debt/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt/EBITDA
Date
Debt/EBITDA
Jan 1, 2019
10.58 INR
Jan 1, 2020
4.38 INR
Jan 1, 2021
4.31 INR
Jan 1, 2022
2.44 INR
Jan 1, 2023
1.73 INR
Jan 1, 2024
0.96 INR
Jan 1, 2025
0.77 INR
Jan 1, 2026
1.71 INR
The Global Health Debt/EBITDA history
YEARDebt/EBITDAYoY
1.71+121.49%
0.77-20.06%
0.96-44.18%
1.73-29.13%
2.44-43.45%
4.31-1.56%
4.38-58.58%
10.58+314.30%
2.55—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Global Health Stock analysis

What does Global Health do? Global Health Ltd. provides healthcare, pathology, and medical services through its Medanta brand, operating five hospitals in Delhi, Gurugram, Indore, Ranchi, Patna, and Lucknow, alongside six Mediclinic diagnostic laboratories. The company generates revenue by delivering treatments for conditions such as coronary artery disease, head and neck cancer, acute myeloid leukemia, and chronic kidney disease, alongside specialized services in cardiac surgery, nephrology, urology, and interventional cardiology. Its offerings include medicine delivery, lab tests & diagnostics, homecare, and telemedicine, targeting patients seeking advanced medical care across multiple specialties. Medanta serves urban and semi-urban segments in India, focusing on high-demand treatments and comprehensive healthcare solutions. The company monetizes through direct patient services at its hospitals and diagnostic centers, with revenue derived from procedures, consultations, and diagnostic tests. Treatments for chronic conditions like diabetes, hypertension, and bronchial asthma, as well as acute cases such as cerebral stroke and sepsis, form a significant portion of its service portfolio. Patients utilize Medanta’s telemedicine and homecare services for convenience, while its diagnostic labs provide lab tests & diagnostics to both in-person and remote clients. Revenue streams are driven by high-volume treatments and specialized medical expertise across its network of facilities. Medanta’s service mix includes cardiology, oncology, neurology, and orthopedics, with a focus on conditions like Parkinson’s disease, prostate cancer, and rheumatoid arthritis. The company’s revenue model relies on comprehensive care packages, including hospital stays, outpatient visits, and follow-up services. Its facilities in Delhi, Gurugram, and other cities cater to both private and government-affiliated patients, though the business description does not specify government contracts. The company’s diagnostic laboratories and telemedicine services expand its reach, enabling revenue from multiple touchpoints within the healthcare ecosystem. Global Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Global Health stock

Total Debt to EBITDA Ratio of Global Health is 1.71 in 2026.

Total Debt to EBITDA Ratio of Global Health changed from 0.77 to 1.71, representing a 121.49% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Total Debt to EBITDA Ratio Global Health since 2006 – with annual values, charts, and detailed analysis.

Debt/EBITDA measures total debt relative to earnings before interest, taxes, depreciation, and amortization. It indicates the years needed to repay all debt from EBITDA.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Total Debt to EBITDA Ratio's Global Health with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Global Health

All Key Metrics — Global Health